Skip to main content
All lobbying filings

VENABLE LLP

Lobbying for AMERICAN ASSOCIATION OF PSYCHIATRIC PHARMACISTS · Non-Profit, National Membership Organization for Psychiatric Pharmacists

 Filing · LD-2 quarterly report Q1 report
Reporting period
1st Quarter 2025
Jan 1 - Mar 31 · Posted Apr 7, 2025
Income
$30,000
What the client paid this registrant for the period.
Client based in
Nebraska

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1
Health Issues

Increasing access to mental health and substance use treatment, including Methadone; Mental health & substance use disorder workforce; H.R. 1708/S. 1087, Rebuild America's Health Care Schools Act; Protect Medicaid from cuts; Federal funding for mental health and substance use programs, research and training; Medicare telehealth flexibilities; H.R. 2482, Reauthorization of Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities (SUPPORT) Act; H.R. 2509/S. 931, Connecting Our Medical Providers with Links to Expand Tailored and Effective (COMPLETE) Care Act; H.R. 2586, Reentry Act; H.R. 1510, Due Process Continuity of Care Act

 Bills named in this filing 7
  • H.R. 1708
    Rebuild America’s Health Care Schools Act of 2025
  • S. 1087
    Rebuild America’s Health Care Schools Act of 2025
  • H.R. 2482
    To require the Secretary of Defense to conduct a study on the accessibility of mental health care providers and service…
  • H.R. 2509
    COMPLETE Care Act
  • S. 931
    A bill to amend the Internal Revenue Code of 1986 to ensure that the 2021 recovery rebates as provided for in the Ameri…
  • H.R. 2586
    Reentry Act of 2025
  • H.R. 1510
    Due Process Continuity of Care Act

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem